Kevin C. Huang

Taitung, TNQ 41330, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Concurrent P-Selectin Targeting Nanoparticle Orchestrates Tumor-Immune Dynamics for Advanced Immunochemotherapy.

Concurrent P-Selectin Targeting Nanoparticle Orchestrates Tumor-Immune Dynamics for Advanced Immunochemotherapy.

Journal: ACS nano

Published: April 28, 2026

TGFβ Blockade by Inhibition of Enolase-1-Mediated Plasmin Targets Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma.

TGFβ Blockade by Inhibition of Enolase-1-Mediated Plasmin Targets Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma.

Journal: Oncology research

Published: December 19, 2025

Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.

Heterologous prime-boost immunization of AAV-based neoantigen cancer vaccine induces anti-tumor immunity to inhibit tumor growth and relapse.

Journal: Cancer immunology, immunotherapy : CII

Published: November 07, 2025

Targeting PCK1 to overcome CDK4/6 inhibitor resistance for breast cancer therapy.

Targeting PCK1 to overcome CDK4/6 inhibitor resistance for breast cancer therapy.

Journal: Cancer letters

Published: October 21, 2025

Pemetrexed potentiates γδ T cell-based immunotherapy in NSCLC through ATM-STING-NF-κB-mediated induction of NKG2D ligands.

Pemetrexed potentiates γδ T cell-based immunotherapy in NSCLC through ATM-STING-NF-κB-mediated induction of NKG2D ligands.

Journal: International immunopharmacology

Published: September 05, 2025

HERVOminer: a sequence similarity-based approach for recognizing endogenous retrovirus origin of the peptidome.

HERVOminer: a sequence similarity-based approach for recognizing endogenous retrovirus origin of the peptidome.

Journal: NPJ precision oncology

Published: August 12, 2025

Loss of MicroRNA-29b promotes DNMT3b-mediated STING downregulation to attenuate radiotherapy-induced antitumor immunity in KRAS-mutated colorectal cancer.

Loss of MicroRNA-29b promotes DNMT3b-mediated STING downregulation to attenuate radiotherapy-induced antitumor immunity in KRAS-mutated colorectal cancer.

Journal: NPJ precision oncology

Published: May 26, 2025

Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy.

Targeting ENO1 reprograms macrophage polarization to trigger antitumor immunity and improves the therapeutic effect of radiotherapy.

Journal: Cell death & disease

Published: April 24, 2025

Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancer.

Targeting DRP1 promotes radiotherapy-induced antitumor immunity via mitochondrial DNA-mediated cGAS-STING signaling in KRAS-mutated colorectal cancer.

Journal: Cancer letters

Published: March 04, 2025

Dynamic investigation of hypoxia-induced L-lactylation.

Dynamic investigation of hypoxia-induced L-lactylation.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 03, 2025

CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer.

CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer.

Journal: Cell death & disease

Published: January 23, 2025

Prognostic Significance of STK11/LKB1 Expression and Its Role in the Tumor Microenvironment of Colorectal Adenocarcinoma.

Prognostic Significance of STK11/LKB1 Expression and Its Role in the Tumor Microenvironment of Colorectal Adenocarcinoma.

Journal: In vivo (Athens, Greece)

Published: December 30, 2024

Showing 1-12 of 39

Last Updated: 09/26/2026